Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$188M |
| 2 |
Intel
INTC
|
+$178M |
| 3 |
SHPG
Shire pic
SHPG
|
+$177M |
| 4 |
Lowe's Companies
LOW
|
+$105M |
| 5 |
Hain Celestial
HAIN
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$327M |
| 2 |
Encompass Health
EHC
|
+$300M |
| 3 |
Labcorp
LH
|
+$210M |
| 4 |
Humana
HUM
|
+$206M |
| 5 |
Elevance Health
ELV
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.45% |
| 2 | Materials | 11.61% |
| 3 | Communication Services | 10.45% |
| 4 | Technology | 7.95% |
| 5 | Financials | 5.5% |
Similar funds
Glenview Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Glenview Capital Management held 57 positions worth $15.1B, up 1.9% from $14.8B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Glenview Capital Management withdrew a net $1.17B in Q1 2017, closing 5 positions and reducing 27 holdings. Its most notable exit was Encompass Health, an estimated $300M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 52% a quarter earlier, followed by Materials and Communication Services.
Against the trend, Glenview Capital Management opened a new position in Intel worth $178M.
- Glenview Capital Management's largest Q1 2017 buy was Intel: 4,931,557 shares worth $178M.
- Glenview Capital Management added most to DuPont de Nemours in Q1 2017, an estimated $188M increase.
- Glenview Capital Management's biggest Q1 2017 reduction was HCA Healthcare, cutting an estimated $327M.
- Glenview Capital Management fully exited Encompass Health in Q1 2017, selling an estimated $300M.
- Glenview Capital Management's ten largest holdings make up 51% of its $15.1B portfolio in Q1 2017.
- Glenview Capital Management opened 8 new positions and closed 5 in Q1 2017.
- Glenview Capital Management's portfolio value rose 1.9% quarter-over-quarter to $15.1B.
Based on Glenview Capital Management's 13F filing for Q1 2017, filed 15 May 2017.